CITRAVESCENT granules sachet (reformulation)

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

sodium bicarbonate, Quantity: 1.32 g; citric acid, Quantity: 1.23 g; tartaric acid, Quantity: 0.4 g; sodium carbonate, Quantity: 0.08 g

Disponível em:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

DCI (Denominação Comum Internacional):

citric acid,sodium bicarbonate,sodium carbonate,tartaric acid

Forma farmacêutica:

Granules, effervescent

Composição:

Excipient Ingredients: lactose monohydrate; sucrose

Via de administração:

Oral

Unidades em pacote:

8 sachets, 10 sachets, 25 sachets, 28 sachets, 20 sachets

Tipo de prescrição:

Not scheduled. Not considered by committee

Indicações terapêuticas:

Systemic and urinary alkalinisation where indicated in the relief of symptoms associated with urinary tract infections such as cystitis, pyelonephritis, urethritis; and in reducing the formation of uric acid and cystine calculi. Citravescent may increase the effectiveness of sulphonamide antibiotics in the treatment of urinary tract infection. Acid indigestion or heartburn.

Resumo do produto:

Visual Identification: White granules; Container Type: Sachet; Container Material: Al laminated with LDPE/paper; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Status de autorização:

Licence status A

Data de autorização:

2013-08-15